Pancreatic Cancer Research

ResearcherArizona State UniversityNo recent work listed

Grant McFadden

Matched on ORCID iD 0000-0002-2556-3526; OpenAlex author ID A5040591138; NIH RePORTER profile ID 8806212.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
4 (first author 0, last author 3)
Pancreatic cancer trials
0
Pancreatic cancer grants
1
Labs led
1
Collaborators
3
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper, 1 grant · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper

Papers 4

  1. Combination of LIGHT (TNFSF14)-Armed Myxoma Virus Pre-Loaded into ADSCs and Gemcitabine in the Treatment of Experimental Orthotopic Murine Pancreatic Adenocarc… Last author DOI 10.3390/cancers14082022↗
  2. Myxoma Virus Expressing LIGHT (TNFSF14) Pre-Loaded into Adipose-Derived Mesenchymal Stem Cells Is Effective Treatment for Murine Pancreatic Adenocarcinoma. Co-author DOI 10.3390/cancers13061394↗
  3. Myxoma virus sensitizes cancer cells to gemcitabine and is an effective oncolytic virotherapeutic in models of disseminated pancreatic cancer. Last author DOI 10.1038/mt.2011.293↗
  4. Oncolytic virotherapy for pancreatic cancer. Last author DOI 10.1017/s1462399411001876↗

Grants 1

  1. Virotherapy for pancreatic cancer with wildtype and armed Myxoma viruses R21CA149869↗

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Joanna Jazowiecka-Rakus · 2 shared papers, 2021–2022
  2. Aleksander Sochanik · 2 shared papers, 2021–2022
  3. Sonia Tusell Wennier · 2 shared papers, 2011–2012

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.